A61K 39/105
Delta proteobacteriales
Official title: {Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter}
A61K39/105 (Delta proteobacteriales) appears on 177 US grants and 224 published applications in this corpus.
Search patents in A61K- Granted patents
- 177
- Published applications
- 224
- Assignees
- 113
- Inventors
- 359
- Latest grant
- 23 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 6 | 0 |
| 2000 | 5 | 0 |
| 2001 | 3 | 2 |
| 2002 | 4 | 8 |
| 2003 | 7 | 5 |
| 2004 | 4 | 5 |
| 2005 | 4 | 9 |
| 2006 | 4 | 11 |
| 2007 | 3 | 13 |
| 2008 | 1 | 8 |
| 2009 | 4 | 8 |
| 2010 | 5 | 6 |
| 2011 | 3 | 10 |
| 2012 | 8 | 10 |
| 2013 | 6 | 14 |
| 2014 | 7 | 7 |
| 2015 | 13 | 12 |
| 2016 | 9 | 13 |
| 2017 | 6 | 12 |
| 2018 | 18 | 11 |
| 2019 | 9 | 12 |
| 2020 | 12 | 12 |
| 2021 | 12 | 12 |
| 2022 | 3 | 5 |
| 2023 | 6 | 5 |
| 2024 | 5 | 9 |
| 2025 | 3 | 4 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production23 Sep 2025US 12,419,947 B2Najit Technologies, Inc.
- Attenuated salmonella synthesizing antigens for vaccinating against helicobacter pylori29 Jul 2025US 12,370,248 B2University of Florida Research Foundation, Inc.
- Application of heptoglycan-chain-containing oligosaccharide compounds in preparation of vaccine against Helicobacter pylori10 Jun 2025US 12,324,832 B2Jiangnan University
- Method for synthesizing O-antigen saccharide chain of Helicobacter pylori serotype O:624 Dec 2024US 12,173,024 B2Jiangnan University
- Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process1 Oct 2024US 12,102,676 B2Najit Technologies, Inc.
- Methods for preventing the development of a gastric disease associated with helicobacter pylori infection without eradicating the infection and for the assessment of the risk of developing such disease2 Apr 2026US 2026/0091099 A1
- Vaccine against campylobacter jejuni27 Nov 2025US 2025/0360193 A1
- IgY Antibody Compositions and Methods for Treating Avian Species25 Sep 2025US 2025/0295770 A1Mammal Labs Inc.
- Preparation of live vaccines5 Jun 2025US 2025/0177508 A1Elanco Tiergesundheit AG
- Vaccination with mica/b alpha 3 domain for the treatment of cancer27 Feb 2025US 2025/0064863 A1Dana-Farber Cancer Institute, Inc.
Most cited
By later US patents
- Antigen delivery system and method of production121US 6,838,089 B1AstraZeneca AB · 2005
- Antigen library immunization76US 6,541,011 B2Maxygen, Inc. · 2003
- Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents70US 5,885,823 ANOBL Laboratories, Inc. · 1999
- Mutant cholera holotoxin as an adjuvant43US 7,384,640 B1The United States of America as represented by the Uniformed Services University of Health Sciences · 2008
- Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof36US 7,312,065 B2Boehringer Ingelheim Vetmedica GmbH · 2007